Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 4/20 | 0.39 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.39 |
| ▸ | PTGFR | P43088 | 1/20 | 0.39 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.39 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.31 |
| ▸ | KLK1 | P06870 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22276343 | 0.95 | PTGER4 (0.39) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276176 | 0.93 | TBXA2R (0.37) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276339 | 0.93 | PTGER4 (0.37) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL23890399 | 0.91 | PTGER3 (0.36) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276230 | 0.91 | TBXA2R (0.36) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276146 | 0.91 | TBXA2R (0.36) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276163 | 0.90 | PTGER4 (0.39) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL23890345 | 0.88 | TBXA2R (0.35) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL22276155 | 0.87 | PTGER4 (0.38) | PTGER4PTGDRTBXA2RPTGER1PTGFR | |
| SCHEMBL23890360 | 0.87 | TBXA2R (0.34) | PTGER4PTGDRTBXA2RPTGER1PTGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3889134-A1 | COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF | Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) | 2021-10-06 | — | — | EP | disclosed |
| WO-2020151566-A1 | COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF | 凯复制药有限公司 | 2020-07-30 | — | — | WO | disclosed |